Estudo da degradação forçada em meio alcalino do molnupiravir por cromatografia eletrocinética micelar capilar
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
COVID-19 is an infectious disease caused by the SARS-CoV-2 coronavirus, which was
declared a pandemic by the World Health Organization (WHO) in March 2021, and still
represents a threat to public health. Currently, some drugs are recommended by the WHO as a
therapeutic approach to tackling the health crisis. Among them, molnupiravir is the first oral
anti-SARS-CoV-2 antiviral to be approved by the health agencies of several countries,
including Brazil. Given the recent nature of antiviral therapies to combat COVID-19, ensuring
appropriate safety and efficacy in the production of these drugs depends on guaranteeing the
quality control of raw materials. Molnupiravir is a prodrug of β-D-N
4
-hydroxycytidine (NHC),
a strategy for increasing bioavailability. In addition, NHC is reported as a by-product in several
total synthetic routes and a metabolite of molnupiravir, considerations that highlight the need
for simultaneous monitoring of both substances in the context of pharmaceutical products. The
aim of this work was to develop and optimize an analytical method for the analysis of
molnupiravir in raw materials, and to apply this methodology in an investigative approach to
the forced degradation study (FDS). In its development, the separation of molnupiravir and
NHC was evaluated by zone capillary electrophoresis techniques: in free solution and in
micellar phase, using diode array detection at 236 nm. The electrolyte was optimized using a
3
2
factorial design, in which the influence of the pH value and the micellar concentration on the
separation efficiency of the drugs was evaluated. The optimized method consisted of the
analysis of molnupiravir by micellar electrokinetic capillary chromatography using a fused
silica capillary externally coated with polyamide with a total length of 48.5 cm (40.0 cm
effective), 75 μm internal diameter; cartridge temperature maintained at 25.0 ºC; positive
voltage of 20 kV; hydrodynamic injection of 25 mbar for 4s; electrolyte consisting of carbonate
buffer solution (NaHCO3/Na2CO3) at a concentration of 20 mmol L-1
, pH 10.4, and SDS at a
concentration of 60 mmol L-1
; with a total analysis time of 12 minutes. Some analytical
performance parameters were evaluated, so that selectivity was certified, and the accuracy of
the method, whose values range from 91 to 113%, was established by recovery tests at three
concentration levels. No impurities were found in the raw material analyzed. Assessing the
chemical stability of pharmaceutical formulations is a public health issue since instability can
reduce the therapeutic effect or expose users to potentially toxic degradation products (DPs).
Therefore, the FDS was carried out by exposing the raw material to stress conditions in an
alkaline environment. Based on the analytical methodology implemented, up to five
degradation products were detected. One of these DPs is estimated to be NHC, considering the
characterization by UV-VIS spectroscopy, demonstrating the potential of the method as an
indicator of stability in the experimental setting investigated, assisting in other FDS under other
stress conditions, and in the development of future formulations.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

